Short description
We make Better Cannabinoids through sustainable biotechnology.
Description
We’re a bioengineering company that's reducing the massive environmental footprint of the CBD market through precision fermentation. And our technology never touches a plant.
CBD is a global $12Bn consumer market and Hyasynth's precision fermentation platform eliminates wasteful plant cultivation and decreases the carbon impact by more than 97%.
Hyasynth is the world's only bioengineering company with a scalable, fermentation process for CBD that is cost-efficient and regulatory-compliant.
Total funding
$$2020202
Sign in for full access
Location
Montréal, Quebec, Canada, North America
Founded on
May 1, 2014
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Noaccess, Noway Youcantaccess, No Way, Cannot Access, Noaccess, Nopepepe, Noaccess, Blurry Noaccess
Sign in for full access
Founders
Alex Campbell, Kevin Chen, Shoham Mookerjee, Si Ch, Zach Wiltshire